Recurrent thromboembolism in ovarian cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 12, 2004, Pages 1218-1220

  Fuglsang, Jens ^a   Ingerslev, Jørgen ^a   Havsteen, Hanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

LMWH; Ovarian cancer; Thromboembolism; Thrombosis

Indexed keywords

CARBOPLATIN; ENOXAPARIN; EPIRUBICIN; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CHRONIC DRUG ADMINISTRATION; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LUNG EMBOLISM; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT THROMBOEMBOLISM; THROMBOEMBOLISM;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CYSTADENOCARCINOMA, SEROUS; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RECURRENCE; THROMBOEMBOLISM; WARFARIN;

EID: 10344234722     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.0133a.x     Document Type: Article

References (13)

1. Green KB, Silverstein RL. Hypercoagulability in cancer. Hemat Onc Clin North Am 1996; 10: 499-530.
2. Sack GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 1977; 56: 1-37.
3. Hillen HFP. Thrombosis in cancer patients. Ann Oncol 2000; 11: 273-6.
4. von Tempelhoff GF, Dietrich M, Niemann F, Schneider D, Hommel G, Heilmann L. Blood coagulation and thrombosis in patients with ovarian malignancy. Thromb Haemost 1997; 77: 456-61.
5. Evans TRJ, Mansi JL, Bevan DH. Trousseau's syndrome in association with ovarian carcinoma. Cancer 1996; 77: 2544-9.
6. Kakkar AK, de lorenzo F, Pineo GF, Williamson RCN. Venous thromboembolism and cancer. Baillières Clin Haematol 1998; 11: 675-87.
7. Gouin-Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost 1999; 25: 167-72.
8. Walsh-McMonagle D, Green D. Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer 1997; 80: 649-55.
9. Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 1985; 79: 423-30.
10. Callander N, Rapaport SI. Trousseau's syndrome. West J Med 1993; 158: 364-71.
11. Züger M, Demarmels Biasiutti F, Wuillemin WA, Furlan M, Lämmle B. Subcutaneous low-molecular-weight heparin for treatment of Trousseau's syndrome. Ann Haematol 1997; 75: 165-7.
12. Morita S, Gebska MA, Kakkar AK, Scully MF. High affinity binding of heparin by necrotic tumor cells neutralises anticoagulant activity. Thromb Haemost 2001; 86: 616-22.
13. Kakkar AK, Williamson RCN. Antithrombotic therapy in cancer. Br Med J 1999; 318: 1571-2.